In this talk, Murat speaks with Ming (Tommy) Tang, Director of Computational Biology at Immunitas Therapeutics, an immuno-oncology start-up developing novel therapeutics for patients with cancer. 

Tommy is a strong leader and communicator in the field of computational biology. He has dedicated his life's work to accelerating cancer research, with prominent expertise in analysing large-scale bulk sequencing data, single-cell and spatial transcriptomic data and epigenetic data.

Outside of his career at Immunitas, Tommy is a brilliant science communicator and teacher, with various educational streams, including Twitter, a blog, a GitHub repository, a YouTube channel, a newsletter, as well as authoring his own book, 'From Cell Line To Command Line'. He is passionate about teaching biologists the computational skills essential for modern science. 

You will learn:

• How to stay ahead of the curve: developing the data analysis and bioinformatics skills essential to modern research.


• How Immunitas is developing a discovery engine to aid the fight against cancer and the computational workflows behind it.


• How to transition from a biologist to a computational biologist.


• About the shift from academia to industry.


• About Tommy's inspiring journey.

Things mentioned:

Link to all Tommy's resources: https://tommytang.bio.link/

• Shanghai Jiao Tong University


• University of Florida


• MOOC Platforms: Udacity, Coursera, edX


• Biostars


• MD Anderson Cancer Center


• Roel Verhaak
  


• Cancer Genome Atlas Project


• Harvard Faculty of Arts and Sciences


• Shirley Liu's group at Dana Farber


• Cancer Immunological Data Commons


• Mount Sinai


• Stanford


• Tommy's Blog: https://divingintogeneticsandgenomics.com/


• Immunitas's lead candidate: CD161 / IMT-009 / KORV1


• Workflow management systems: SnakeMake, Nextflow...


• Visgene


• Matthew Berstein


• PD-1


• Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds.

Additional Materials: 

• ⁠⁠⁠⁠⁠⁠⁠⁠⁠Watch the recording of the live event! ⁠https://youtu.be/CYa9rDFDaaI

First time hearing about Antiverse?

Antiverse is an artificial intelligence-driven techbio company that specialises in antibody design against difficult-to-drug targets, including G-protein coupled receptors (GPCRs) and ion channels. Headquartered in Cardiff, UK and with offices in Boston, MA, Antiverse combines state-of-the-art machine learning techniques and advanced cell line engineering to develop de novo antibody therapeutics. With a main focus on establishing long-term partnerships, Antiverse has collaborated with two top 20 global pharmaceutical companies. In addition, they are developing a strong internal pipeline of antibodies against several challenging drug targets across various indications.

For more information, please visit ⁠⁠https://www.antiverse.io⁠⁠

Never miss a future event!

We'll notify you when there's a new event scheduled. Fill out ⁠⁠⁠this form⁠⁠⁠ to sign up for marketing communications from Antiverse. We post about upcoming events on LinkedIn and Twitter.

LinkedIn: ⁠⁠⁠https://www.linkedin.com/company/antiverse/⁠⁠⁠

X: ⁠⁠⁠https://twitter.com/AntiverseHQ⁠